Rapid HIV Testing Program in the Emergency Department
NCT00548041 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2015-11-02
Summary
The purpose of the study is to evaluate the feasibility of a rapid HIV testing program in the Temple University Hospital(TUH)Emergency Department. We hypothesize that a rapid HIV testing program in the TUH Emergency Department is feasible. Patients presenting to the Adult TUH Emergency Department with certain conditions will be offered rapid HIV testing. Testing will be performed by oral swab using the OraQuick Advance test. Patients will receive post-test counseling.
Conditions
- HIV Infections
Interventions
- OTHER
-
HIV test by oral swab
Eligible subjects underwent rapid HIV testing by oral swab.
Sponsors & Collaborators
- collaborator INDUSTRY
-
Temple University
lead OTHER
Principal Investigators
-
Ellen Tedaldi, M.D. · Temple University
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-04-30
- Primary Completion
- 2009-05-31
- Completion
- 2009-05-31
Countries
- United States
Study Locations
More Related Trials
-
Study Evaluating Vaccine in Adults With HIV
NCT00195312 ·Status: TERMINATED ·Phase: PHASE1
-
Study of Anti-HIV Therapy Intensification
NCT00034086 ·Status: COMPLETED ·Phase: NA
-
Safety and Immune Response Assessment Study of Killed-whole HIV-1 Vaccine (SAV001-H) in Chronic HIV-1 Infected Patients
NCT01546818 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection
NCT00002441 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of AGS-004 During Analytical Treatment Interruption
NCT01069809 ·Status: COMPLETED ·Phase: PHASE2
-
H1N1 Influenza Vaccine Immunogenicity in HIV-1 Infected Patients
NCT01111162 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity of Stabilized CH505 TF chTrimer Vaccination in Adults Living With HIV-1 on Suppressive Antiretroviral Therapy
NCT06680479 ·Status: SUSPENDED ·Phase: PHASE1
-
An Antiretroviral Treatment Interruption (ATI) Study to Evaluate the Impact of Genetically Modified Autologous Cells (AGT103-T) to Suppress Human Immunodeficiency Virus Replication in the Absence of Antiretroviral Therapy
NCT05540964 ·Status: UNKNOWN
-
Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection
NCT04925752 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Safety, PK and Antiviral Activity of PGT121 Monoclonal Antibody in HIV-uninfected and HIV-infected Adults
NCT02960581 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Uninfected Adults
NCT00054860 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Zidovudine and T Lymphocyte Transfer in the Treatment of HIV Type III in Patients With AIDS
NCT00002285 ·Status: COMPLETED ·Phase: NA
-
Prevention of Varicella Zoster Virus (VZV)-Reactivation in HIV-positive Individuals Enrolled in a Prospective Immunogenicity and Safety Trial of VZV Vaccine: PROVE-IT-Study
NCT01213810 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Evaluating the Safety and Immune Response to Three HIV Vaccine Schedules in Healthy, HIV-Uninfected Adults
NCT01783977 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial of PGDM1400 and PGT121 and VRC07-523LS Monoclonal Antibodies in HIV-infected and HIV-uninfected Adults
NCT03205917 ·Status: COMPLETED ·Phase: PHASE1
-
Validation of a Simple and Cost-Effective Nucleic Acid Test for HIV Detection
NCT01084954 ·Status: COMPLETED
-
Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection
NCT00125099 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)
NCT00005001 ·Status: COMPLETED ·Phase: PHASE2
-
Safety of and Immune Response to Two Different HIV Vaccines, Each Followed by a Adenoviral Vaccine Boost, in HIV Uninfected Adults
NCT00270218 ·Status: COMPLETED ·Phase: PHASE1
-
HVTN Protocol 204 - A Phase II Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA016-00-VP, Followed by a Multiclade Recombinant Adenoviral Vector HIV-1 Vaccine Boost, VRCHIVADV014-00-VP, in HIV-1 Uninfected Adult Participants
NCT00125970 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Safety and Immunogenicity of an HIV-1 Vaccine Regimen of Adjuvanted UVAX-1107 Followed by Adjuvanted UVAX-1107 or Adjuvanted UVAX-1197 in Healthy Subjects Aged 25-55 Years.
NCT06541093 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests
NCT01790633 ·Status: COMPLETED ·Phase: NA
-
Phase I Safety and Immunogenicity Vaccine Trial Against HIV/AIDS
NCT00505401 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of and Immune Response to a DNA HIV Vaccine Followed by an Adenoviral Vaccine Boost Given Three Different Ways to HIV Uninfected Adults
NCT00384787 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
NCT05719441 ·Status: RECRUITING ·Phase: PHASE2